Mar-Apr 2014
.


 

Hill-Rom’s Progressa Bed enables optimal therapeutic positioning

Hill-Rom’s ‘Progressa Bed System’ is more than just a bed, with the help of the Progressa Bed System’s integrated functionality and lift system, caregivers can maintain optimal therapeutic positioning, deliver evidence-based therapies and help restore mobility to minimize the risk of cardiovascular, respiratory, metabolic and muscular disorders, as well as delirium.

‘StayInPlace’ is a ground-breaking technology that is only available with the Progressa Bed System which prevents patient migration; hence, minimizing the need for patient repositioning.

The Progressa Bed System is the only ICU bed platform on the market that meets the needs of Critical Care patients in different ICU disciplines through upgradability and configurability.

The Progressa Bed System can be configured and upgraded to meet a wide range of requirements within a hospital, while providing a consistently superior user experience. You can decrease total-cost-ofownership by using ONE supplier to reduce maintenance, spare parts and training costs.

Clinical efficiency provided by the Progressa Bed System: n Eases the individual steps of Progressive Mobility at every level of patient acuity and tolerance n Significantly contributes to shortening ICU length of stay n Enables Progressive Mobility while reducing the risk of adverse events such as line displacement n Shortens time to first out of bed

For more information, contact: eemea@Hill-Rom.com


Medtronic releases world’s smallest implantable cardiac monitoring device

Medtronic have received US FDA 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of its Reveal LINQ Insertable Cardiac Monitor (ICM) System, the smallest implantable cardiac monitoring device available for patients.

The Reveal LINQ ICM is approximately one-third the size of a AAA battery (~1 cc), making it more than 80% smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20% more data memory than its larger predecessor, Reveal XT.

In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events.

The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias. “The Reveal LINQ ICM monitor can help patients find answers to problems that may be heart-related without interrupting their lifestyle,” said Rod Passman, M.D., professor and associate director of cardiac electrophysiology at the Northwestern University Feinberg School of Medicine in Chicago.

“The simplified procedure and insertion tools make the device faster and easier for physicians to implant, which may expand access to more patients needing long-term monitoring.” Placed just beneath the skin through a small incision of less than 1 cm in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients.

The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed. “This miniaturized monitoring system is the result of many years of product development work from engineers focused on shrinking the size of medical devices while maintaining their power and improving benefits for patients,” said Pat Mackin, president of the Cardiac Rhythm Disease Management business and senior vice president at Medtronic. “This is game-changing technology for patients who need cardiac monitoring, and we look forward to providing them with the most technologically advanced and minimally invasive approach possible.”

The Reveal LINQ system also includes the new MyCareLink Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.

“This is a technology that is going to help us reach more patients at risk for cardiac arrhythmias and help healthcare systems more efficiently manage difficult patient populations,” said Randy Lieberman, MD, director of electrophysiology at Detroit Medical Center.

For more information, visit www.RevealLINQ.com

Intersurgical OroCare range extension

Oral hygiene has become a standard procedure in the fight against Ventilator associated pneumonia (VAP) in today’s hospitals. Intersurgical is introducing an extended range of oral care products to meet the increasing diversified needs of the practitioners. OroCare Aspire is a new toothbrush with suction-only properties.

This brush closes the gap between simple brushes and high suction-and-irrigation brushes. OroCare Aspire features a user-friendly design and the usual Intersurgical quality. OroCare Sensitive completes our extensive range. It is designed for use on patients without teeth or with extremely sensitive gums. This oral suction wand has many advantages over conventional suction swabs and features a uniquely designed head.

The OroCare suction line splitter allows the use of two suction lines on a single vacuum canister. This is necessary, when a closed suction system is in use on the patient and simultaneously a suction toothbrush is used for oral hygiene.

For more information on this new range, visit: www.Intersurgical.com/info/oralcare

Masimo’s award-winning iSpO2 pulse oximeter now available for Android

          

Masimo’s award-winning iSpO2 pulse oximeter is now available for Android, along with the companion iSpO2 app downloaded from the Google Play Store. With the release of iSpO2 in the popular Android operating system, more consumers now have access to Masimo SET Measure-through Motion and Low Perfusion pulse oximetry – the same technology used in leading hospitals worldwide.

SpO2 provides accurate, real-time oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI) readings – ideal for anyone who desires access to accurate health data through their mobile devices.

Dr. Mark Hom, MD, co-author of forthcoming exercise books with three-time Tour de France champion Greg LeMond, and Dr Glenn A. Gaesser, PhD, said: “Although we advocate intense training, we don’t recommend that healthy athletes train to the point of oxygen desaturation (i.e., cyanosis). However, our preliminary testing with the iSpO2 has shown that it has the accuracy and repeatability to show subtle changes in athletic oxygenation: specifically in warm-up, steady state, super high intensity, and recovery. And as an added benefit, the iSpO2 is compact enough to be useful when training on the road or track.”

Dr Kirk Shelley, MD, PhD, professor of anesthesiology at Yale University in New Haven, Connecticut, commented: “This pulse oximeter is without a doubt the best one available for the consumer market. Masimo uses impressive digital signal processing combined with proprietary light emitting diode (LED) technology. If you need a serious pulse oximeter, this is the one to get.”

iSpO2 – extremely lightweight at just 232 grams or about 0.5 pounds – also displays the pleth waveform and Signal IQ so users can visually assess where the pulse is occurring and the quality of the measurement even during motion artifact. iSpO2 can also trend, store, and email up to 12 hours of measurement history in the global standard, .CSV file format, allowing consumers to easily share data through their mobile device email application. iSpO2 is for sports and aviation use; not intended for medical use.

For more information, visit: www.iSpO2.com

Timesco exhibits innovative LED rechargeable batteries

England-based Timesco Healthcare, exhibited with great success at Arab Health their new revolutionary, award winning, patented single-use and reusable handles for laryngoscopy and innovative LED rechargeable batteries and rechargers.

As part of Timesco’s new range of energy efficient and single-use laryngoscopy products, EES and ION, the Timesco ION R batteries provide superb energy savings, LED illumination and a low cost alternative to dry cell and reusable batteries. Complimented with the new Timesco ION R rechargers, each battery has a working life of up to nine years, or 30,000 intubations.

The Timesco microprocessor controlled ION R batteries are lithium ION with LED bulbs enclosed in same battery which provide a constant 43,000 LUX of pure white LED light, a one hour charge will provide up to one year’s use! Timesco ION R batteries are multipurpose and can be used in variety of products such as diagnostic and single use and reusable laryngoscope handles.

Timesco new SUS, clear, single use skins, are new laryngoscopes handles, which prevent cross contamination and are for use with the ION R batteries. Simply insert the ION R battery into the SUS handle and use! The SUS handles are completely sealed, feature an external on/ off switch, ISO fitting to accommodate all fibre laryngoscope blades and are supplied clinically clean; best of all, they are at a throw away cost.

For more information, visit: www.timesco.com

Timesco’s regional Dubai office – contact Misbah Jabbar, e-mail: misbah.jabbar@timesco.com


IMRIS launches world’s first MR-safe and CT-compatible neurosurgical horseshoe headrest

IMRIS has launched the world’s first MRsafe and CT-compatible horseshoe headrest on the market for the positioning of patients ranging from neonatal to adult during neurosurgical procedures requiring intraoperative imaging in the VISIUS Surgical Theatre.

The horseshoe headrest provides nonpinned head support in prone, lateral, and supine positions during head, neck and cervical spine surgeries where use of a head fixation device (HFD) – a clamp-like device – is not desirable because the skull is too fragile for pinning. These patients may be babies whose skulls are still soft or older patients with weakened skull bones.

“The IMRIS horseshoe headrest expands the use of intraoperative imaging to patients who cannot be positioned for surgery with a head fixation device, such as neonatal and young paediatric patients. This headrest may also be useful for other applications not requiring rigid fixation, such as those that access the skull through the nose,” said Dr James Baumgartner, Surgical Director of the Comprehensive Pediatric Epilepsy Center at Florida Hospital.

“This will enhance an already sophisticated technology platform that includes intraoperative MR and the comprehensive team approach we have for paediatric tumour and epilepsy care.”

A spokesperson for the company told Middle East Health that IMRIS has an installation of a three-room intraoperative MRI hybrid operating room suite pending at Sidra Medical and Research Center in Doha. IMRIS President and CEO Jay D. Miller said surgeons at hospitals with VISIUS systems which adopt the headrest will now have an opportunity to benefit both a patient population – including those too small for other positioning devices – and procedures not previously utilized in the surgical theatre.

“We received tremendous feedback and enthusiasm from paediatric neurosurgeons during development of this product,” he said.

“This headrest will allow surgeons to use iMR on more patients who we expect will benefit from the same outcomes, including reduced re-operation rates, which we have recently reported from hospitals.

“In addition, the headrest which is designed for patient comfort and smooth staff workflow includes disposable elements,” Miller said. “This first release in our disposable product portfolio establishes the company’s capabilities to develop tools that speed case-to-case transition and optimize patient handling.”

IMRIS also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment. l For more information, visit: www.imris.com


 Date of upload: 09th Apr 2014

 

                                  
                                                                        Copyright © 2014 MiddleEastHealthMag.com. All Rights Reserved.